hotspot -WSS

hotspot

author：Wikipedia 2025-09-02 13:53:50 - browse：95967

Adam Feuerstein, upper left, moderated a panel with, clockwise, David Chang of Allogene Therapeutics, Rachel Haurwitz of Caribou Biosciences, and Lynelle Hoch of Bristol Myers Squibb. STAT

If you ask biopharma leaders what’s ahead for CAR-T cancer therapy, they say the future is bright. And that future will also look markedly different than it does today, three of them said at the STAT 2023 Future Summit on Wednesday.

Now in its second decade, the cell therapy — which attacks cancer by extracting white blood cells from a patient, genetically modifying them, and then re-infusing them to fight the cancer — has made remarkable strides. Biotech reporter Adam Feuerstein reminded panelists that Emily Whitehead, the first pediatric patient to receive the therapy at age 10, has just started college.

But for all its success in changing the lives of up to 7,000 patients to the point one can use the word “cure,” the field has been hampered by wait lists at manufacturers making these patient-specific, autologous therapies and a shortage of medical centers to administer them. Patients bear a burden, too: Training their B cells to attack their tumors requires an onerous depletion process before their cells can be taken out of their bodies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Attacks on the drug industry will lead to fewer breakthroughs

hotspot

WSS

WATCH: Why do our ears pop?

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

Stem cell clinics for heart failure: buyer be wary

'Ancient DNA,' 23andMe reveal African American ancestries

New CMS data security rules will hurt Medicare, Medicaid research

Weight loss drugs aren’t covered by Obamacare. That may change

knowledge

hotspot

focus

Sports medicine is finally prioritizing gender equality

Nearly two

What does generative AI mean for health care? We asked experts

Measles policy set amid Florida outbreak alarms vaccine proponents

Peter Hotez and the public health issue of online harassment

What Henrietta Lacks settlement says about racism in medicine

After affirmative action ruling, medical educators look to 'holistic review'

Stem cell clinics for heart failure: buyer be wary

Hepatitis C has a cure — but many Americans still lack access to it

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

hotspot

Abridge raises $150m as clinical notes automation market heats up

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Humana, CVS hope to turn members into patients at clinics

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Attacks on the drug industry will lead to fewer breakthroughs

entertainment

hotspot

focus

explore